Loading clinical trials...
Loading clinical trials...
This study will evaluate the safety, toxicity and efficacy of talactoferrin in reducing the incidence of all nosocomial infections in prematurely-born infants.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Agennix
Collaborators
NCT06643039 · Nosocomial Infections
NCT01338116 · Community-associated Infections, Health-care Acquired Infections, and more
NCT01346735 · Nosocomial Infections
NCT00791583 · Nosocomial Infections
NCT00122057 · Respiratory Tract Diseases, Nosocomial Infections
Childrens Hospital of Los Angeles
Los Angeles, California
Kosair Children's Hospital
Louisville, Kentucky
University of Louisville Hospital
Louisville, Kentucky
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions